Mattia Lunardi
Overview
Explore the profile of Mattia Lunardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bianchini F, Romagnoli E, Aurigemma C, Paraggio L, Buffon A, Fracassi F, et al.
JACC Cardiovasc Interv
. 2025 Mar;
PMID: 40071321
Background: "Stepwise provisional stenting" is the most adopted approach for percutaneous coronary interventions (PCI) in bifurcation lesions. During these procedures, side-branch (SB) may deserve treatment, but the best ballooning technique...
2.
Cappannoli L, Colantuono S, Animati F, Fracassi F, Galli M, Aurigemma C, et al.
Biomolecules
. 2024 Oct;
14(10).
PMID: 39456262
Acetylsalicylic acid (ASA) represents a cornerstone of antiplatelet therapy for the treatment of atherosclerotic coronary artery disease (CAD). ASA is in fact indicated in case of an acute coronary syndrome...
3.
Romagnoli E, Bianchini F, Aurigemma C, Zito A, Bianchini E, Paraggio L, et al.
Int J Cardiol Heart Vasc
. 2024 Oct;
55:101523.
PMID: 39445119
Background: Trans-femoral (TF) represents the main access for TAVI. Although there are various technical strategies to conduct TF-TAVI (pacing modality, secondary arterial access, primary access puncture etc.), the optimal technique...
4.
Romagnoli E, Lunardi M, Burzotta F
Eur Heart J
. 2024 Oct;
45(43):4644-4646.
PMID: 39361492
No abstract available.
5.
Bottardi A, Prado G, Lunardi M, Fezzi S, Pesarini G, Tavella D, et al.
J Clin Med
. 2024 Aug;
13(16).
PMID: 39200741
Despite significant goals achieved in diagnosis and treatment in recent decades, coronary artery disease (CAD) remains a high mortality entity and continues to pose substantial challenges to healthcare systems globally....
6.
van Nieuwkerk A, Aarts H, Hemelrijk K, Urbano Carrillo C, Tchetche D, de Brito Jr F, et al.
J Am Heart Assoc
. 2024 Aug;
13(17):e032901.
PMID: 39190595
Background: Cerebrovascular events remain one of the most devastating complications of transcatheter aortic valve implantation (TAVI). Data from real-world contemporary cohorts on longitudinal trends and outcomes remain limited. The aim...
7.
Paraggio L, Bianchini F, Aurigemma C, Romagnoli E, Bianchini E, Zito A, et al.
Circ Cardiovasc Interv
. 2024 Aug;
17(9):e014156.
PMID: 39166330
Transfemoral access is nowadays required for an increasing number of percutaneous procedures, such as structural heart interventions, mechanical circulatory support, and interventional electrophysiology/pacing. Despite technological advancements and improved techniques, these...
8.
Lunardi M, Bianchini F, Aurigemma C, Romagnoli E, Paraggio L, Bianchini E, et al.
Kardiol Pol
. 2024 Aug;
82(9):831-839.
PMID: 39140669
Coronary artery disease (CAD) is prevalent in c. 50% of patients with severe aortic valve stenosis undergoing transcatheter aortic valve implantation (TAVI). The impact of CAD on TAVI outcomes and...
9.
Bianchini E, Basile M, Bianchini F, Zito A, Romagnoli E, Aurigemma C, et al.
Int J Cardiol
. 2024 Jul;
413:132392.
PMID: 39067526
Background: Patients experiencing non-ST segment elevation acute-coronary-syndromes (NSTE-ACS) often present with multivessel-coronary-artery-disease (MVD). An immediate complete multivessel revascularization (MVR) - within the index hospitalization - may be considered the default...
10.
Del Sole P, Lunardi M, Andreaggi S, Fezzi S, Pesarini G, Scarsini R, et al.
J Invasive Cardiol
. 2024 Jul;
36(12).
PMID: 39052515
Objectives: Calcific peripheral artery disease (PAD) is a common finding in patients scheduled for transcatheter aortic valve implantation (TAVI) and often requires iliofemoral axis preparation. However, evidence about the use...